UK-India trade agreement does not support UK life sciences ambitions, says ABPI
The ABPI is disappointed that the deal does not appear to address longstanding industry concerns about intellectual property protections for UK life science innovators within the Indian market…
Read the full articleYou might also wanna read
EDPB/EDPS Joint Opinion on the European Biotech Act Proposal: Key Data Protection Implications for Pharma and Life Sciences

UK Life Sciences Must Move From Innovation Pilots to National Adoption
The UK is not short of innovation. The challenge is building the national systems, funding routes and procurement models needed to turn prom
UK life sciences sector secures £3 billion investment
The UK's life sciences sector has attracted more than £3 billion in new public and private investment over the past 12 months. The post UK l

NHS Fast-tracks Life-changing Medicines in Landmark UK-US Access Overhaul
A new series of NHS pilot schemes could give patients access to innovative medicines months earlier while supporting investment in the UK's
India-UK trade pact: Centre notifies rules for determination of origin of goods
India's Finance Ministry has finalized rules for goods eligible for benefits under the India-UK trade pact, set to begin July 15. This Compr

Analysis: US-UK trade deal could force NHS to divert billions to medicines, critics warn
The NHS will divert billions of pounds from essential services to pay for new medicines under the terms of the US-UK trade deal agreed last

Comments
Sign in to join the conversation.
No comments yet. Be the first.